Oxford Biomedica, AstraZeneca enter new deal for Covid-19 vaccine
According to the new deal, AstraZeneca will have access to Covid-19 vaccine manufacturing at Oxford Biomedica’s Oxbox facility.
Covid-19
Latest in
Covid-19
Pfizer seeks approval from US FDA for Covid-19 treatment
The filing is based on non-clinical and clinical data for Paxlovid and also comprised data from the Phase II/III EPIC-HR…
HDT Bio receives Emergency Use Approval for Covid-19 vaccine in India
Gemcovac became the first saRNA vaccine to obtain approval for use in humans in India.
Pfizer and BioNTech enter $3.2bn deal with US Government for Covid-19 shots
This deal might comprise Omicron-adapted Covid-19 vaccines contingent on obtaining the US FDA authorisation.
Rensselaer team receives NIAID grant to develop antiviral drug for Covid-19
Seven of the ten hepatitis C therapies analysed were found to suppress the SARS-CoV-2 virus.
Covid-19 vaccines targeting Omicron variants expected to be ready this autumn
Leading mRNA Covid-19 vaccine developers race to get their variant-specific boosters authorized, as newer subvariants start to become dominant.
By
Novavax’s Covid-19 vaccine gets Taiwan FDA EUA for use in adults
The vaccine doses for Taiwan would be the first shipment to a nation participating in the COVAX Facility.
UNH team finds repurposed drug hinders enzyme activity linked to Covid-19
The team found that a TDZD compound could hinder the Mpro enzyme, which functions as a molecular scissor for viral…